The genetics of cell wall biosynthesis in Mycobacterium tuberculosis

Future Microbiology

Volumn 3, Issue 3, 2008, Pages 299-313

  Goude, Renan ^a   Parish, Tanya ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

Author keywords

Cord factor; Ethambutol; Isoniazid; Lipoarabinomannan; Mycolyl arabinogalactan peptidoglycan; Phthiocerol dimycocerosate; Sulfolipids

Indexed keywords

3 OXOACYL ACYL CARRIER PROTEIN SYNTHASE; ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE; ARABINOGALACTAN; ARABINOSYLTRANSFERASE; BACTERIAL PROTEIN; EMBA PROTEIN; EMBB PROTEIN; ETHAMBUTOL; ETHIONAMIDE; GLYCOSYLTRANSFERASE; ISONIAZID; LIPID; LIPOARABINOMANNAN; LIPOMANNAN; MANNAN; MANNOSIDE; MANNOSYLTRANSFERASE; MYCOLIC ACID; PEPTIDOGLYCAN; PHENOLIC GLYCOLIPID; PHOSPHATIDYLINOSITOL; PHTHIOCEROL DIMYCOCEROSATE; POLYKETIDE SYNTHASE; SUGAR; SULFOTRANSFERASE; TREHALOSE;

ANTIBIOTIC RESISTANCE; BACTERIAL CELL WALL; BACTERIAL GENETICS; BACTERIAL VIRULENCE; BIOSYNTHESIS; CATALYSIS; ENZYME ACTIVITY; FATTY ACID METABOLISM; GENE CONTROL; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE STRUCTURE; GLYCOSYLATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; CELL WALL; CHEMISTRY; GENETICS; METABOLISM;

MYCOBACTERIUM TUBERCULOSIS;

BIOSYNTHETIC PATHWAYS; CELL WALL; GENE EXPRESSION REGULATION, BACTERIAL; MYCOBACTERIUM TUBERCULOSIS;

EID: 46049109766     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460913.3.3.299     Document Type: Review

References (126)

1. Briken V, Porcelli SA, Besra GS, Kremer L: Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol. Microbiol. 53, 391-403 (2004).
2. Hunter RL, Olsen MR, Jagannath C, Actor JK: Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease. Ann. Clin. Lab. Sci. 36, 371-386 (2006).
3. Cole ST, Brosch R, Parkhill J et al.: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537-544 (1998).
4. Dover LG, Alderwick LJ, Brown AK, Futterer K, Besra GS: Regulation of cell wall synthesis and growth. Curr. Mol. Med. 7, 247-276 (2007).
5. Takayama K, Wang C, Besra GS: Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin. Microbiol. Rev. 18, 81-101 (2005).
6. Amin AG, Goude R, Shi L, Zhang J, Chatterjee D, Parish T: EmbA is an essential arabinosyltransferase in Mycobacterium tuberculosis. Microbiology 154, 240-248 (2008).
7. Sacco E, Covarrubias AS, O'Hare HM et al.: The missing piece of the type II fatty acid synthase system from Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 104, 14628-14633 (2007).
8. Van Heijenoort J: Formation of the glycan chains in the synthesis of bacterial peptidoglycan. Glycobiology 11, 25R-36R (2001).
9. Mahapatra S, Yagi T, Belisle JT et al.: Mycobacterial lipid II is composed of a complex mixture of modified muramyl and peptide moieties linked to decaprenyl phosphate. J. Bacteriol. 187, 2747-2757 (2005).
10. Mikusova K, Belanova M, Kordulakova J et al.: Identification of a novel galactosyl transferase involved in biosynthesis of the mycobacterial cell wall. J. Bacteriol. 188, 6592-6598 (2006).
11. Amer AO, Valvano MA: Conserved aspartic acids are essential for the enzymic activity of the WecA protein initiating the biosynthesis of O-specific lipopolysaccharide and enterobacterial common antigen in Escherichia coli. Microbiology 148, 571-582 (2002).
12. Mills JA, Motichka K, Jucker M et al.: Inactivation of the mycobacterial rhamnosyltransferase, which is needed for the formation of the arabinogalactan-peptidoglycan linker, leads to irreversible loss of viability. J. Biol. Chem. 279, 43540-43546 (2004).
13. Pan F, Jackson M, Ma Y, McNeil M: Cell wall core galactofuran synthesis is essential for growth of mycobacteria. J. Bacteriol. 183, 3991-3998 (2001).
14. Rose NL, Completo GC, Lin SJ, McNeil M, Palcic MM, Lowary TL: Expression, purification, and characterization of a galactofuranosyltransferase involved in Mycobacterium tuberculosis arabinogalactan biosynthesis. J. Am. Chem. Soc. 128, 6721-6729 (2006).
15. Alderwick LJ, Dover LG, Veerapen N et al.: Expression, purification and characterisation of soluble GlfT and the identification of a novel galactofuranosyltransferase Rv3782 involved in priming GlfT-mediated galactan polymerisation in Mycobacterium tuberculosis. Protein Expr. Purif. 58, 332-341 (2008).
16. Belanova M, Dianiskova P, Brennan PJ et al.: Galactosyl transferases in mycobacterial cell wall synthesis. J. Bacteriol. 190, 1141-1145 (2008).
17. Kremer L, Dover LG, Morehouse C et al.: Galactan biosynthesis in Mycobacterium tuberculosis. Identification of a bifunctional UDP-galactofuranosyltransferase. J. Biol. Chem. 276, 26430-26440 (2001).
18. Alderwick LJ, Seidel M, Sahm H, Besra GS, Eggeling L: Identification of a novel arabinofuranosyltransferase (AftA) involved in cell wall arabinan biosynthesis in Mycobacterium tuberculosis. J. Biol. Chem. 281, 15653-15661 (2006).
19. Escuyer VE, Lety MA, Torrelles JB et al.: The role of the embA and embB gene products in the biosynthesis of the terminal hexaarabinofuranosyl motif of Mycobacterium smegmatis arabinogalactan. J. Biol. Chem. 276, 48854-48862 (2001).
20. Zhang N, Torrelles JB, McNeil MR et al.: The Emb proteins of mycobacteria direct arabinosylation of lipoarabinomannan and arabinogalactan via an N-terminal recognition region and a C-terminal synthetic region. Mol. Microbiol. 50, 69-76 (2003).
21. Alderwick LJ, Radmacher E, Seidel M et al.: Deletion of Cg-emb in corynebacterianeae leads to a novel truncated cell wall arabinogalactan, whereas inactivation of Cg-ubiA results in an arabinan-deficient mutant with a cell wall galactan core. J. Biol. Chem. 280, 32362-32371 (2005).
22. Huang H, Scherman MS, D'Haeze W et al.: Identification and active expression of the Mycobacterium tuberculosis gene encoding 5-phospho-{α}-d-ribose-1-diphosphate: decaprenyl-phosphate 5- phosphoribosyltransferase, the first enzyme committed to decaprenylphosphoryl-d- arabinose synthesis. J. Biol. Chem. 280, 24539-24543 (2005).
23. Mikusova K, Huang H, Yagi T et al.: Decaprenylphosphoryl arabinofuranose, the donor of the D-arabinofuranosyl residues of mycobacterial arabinan, is formed via a two-step epimerization of decaprenylphosphoryl ribose. J. Bacteriol. 187, 8020-8025 (2005).
24. Ramaswamy SV, Amin AG, Goksel S et al.: Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 44, 326-336 (2000).
25. Shen X, Shen GM, Wu J et al.: Association between embB codon 306 mutations and drug resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 51, 2618-2620 (2007).
26. Srivastava S, Garg A, Ayyagari A, Nyati KK, Dhole TN, Dwivedi SK: Nucleotide polymorphism associated with ethambutol resistance in clinical isolates of Mycobacterium tuberculosis. Curr. Microbiol. 53, 401-405 (2006).
27. Sharma K, Gupta M, Pathak M et al.: Transcriptional control of the mycobacterial embCAB operon by PknH through a regulatory protein, EmbR, in vivo. J. Bacteriol. 188, 2936-2944 (2006).
28. Belanger AE, Besra GS, Ford ME et al.: The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol. Proc. Natl Akad. Sci. USA 93, 11919-11924 (1996).
29. Sharma K, Gupta M, Krupa A, Srinivasan N, Singh Y: EmbR, a regulatory protein with ATPase activity, is a substrate of multiple serine/ threonine kinases and phosphatase in Mycobacterium tuberculosis. FEBS J. 273, 2711-2721 (2006).
30. Bhatt A, Fujiwara N, Bhatt K et al.: Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice. Proc. Natl Acad. Sci. USA 104, 5157-5162 (2007).
31. Daniel J, Oh TJ, Lee CM, Kolattukudy PE: AccD6, a member of the Fas II locus, is a functional carboxyltransferase subunit of the acyl-coenzyme A carboxylase in Mycobacterium tuberculosis. J. Bacteriol. 189, 911-917 (2007).
32. Smith S. Witkowski A, Joshi AK: Structural and functional organization of the animal fatty acid synthase. Prog. Lipid Res. 42, 289-317 (2003).
33. Veyron-Churlet R, Guerrini O, Mourey L, Daffe M, Zerbib D: Protein-protein interactions within the fatty acid synthase-II system of Mycobacterium tuberculosis are essential for mycobacterial viability. Mol. Microbiol. 54, 1161-1172 (2004).
34. Brown AK, Sridharan S, Kremer L et al.: Probing the mechanism of the Mycobacterium tuberculosis β-ketoacyl-acyl carrier protein synthase III mtFabH: factors influencing catalysis and substrate specificity. J. Biol. Chem. 280, 32539-32547 (2005).
35. Choi KH, Kremer L, Besra GS, Rock CO: Identification and substrate specificity of β-ketoacyl (acyl carrier protein) synthase III (mtFabH) from Mycobacterium tuberculosis. J. Biol. Chem. 275, 28201-28207 (2000).
36. Slayden RA, Barry CE 3rd: The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosis. Tuberculosis (Edinb.) 82, 149-160 (2002).
37. Bhatt A, Kremer L, Dai AZ, Sacchettini JC, Jacobs WR Jr: Conditional depletion of KasA, a key enzyme of mycolic acid biosynthesis, leads to mycobacterial cell lysis. J. Bacteriol. 187, 7596-7606 (2005).
38. Gao LY, Laval F, Lawson EH et al.: Requirement for kasB in Mycobacterium mycolic acid biosynthesis, cell wall impermeability and intracellular survival: implications for therapy. Mol. Microbiol. 49, 1547-1563 (2003).
39. Schaeffer ML, Agnihotri G, Kallender H, Brennan PJ, Lonsdale JT: Expression, purification, and characterization of the Mycobacterium tuberculosis acyl carrier protein, AcpM. Biochim. Biophys. Acta 1532, 67-78 (2001).
40. Huang Y, Ge J, Yao Y, Wang Q, Shen H, Wang H: Characterization and site-directed mutagenesis of the putative novel acyl carrier protein Rv0033 and Rv1344 from Mycobacterium tuberculosis. Biochem. Biophys. Res. Commun. 342, 618-624 (2006).
41. Ghadbane H, Brown AK, Kremer L, Besra GS, Futterer K: Structure of Mycobacterium tuberculosis mtFabD, a malonyl-CoA:acyl carrier protein transacylase (MCAT). Acta Crystallogr. Sect. F Struct. Biol Cryst. Commun. 63, 831-835 (2007).
42. Parish T, Roberts G, Laval F, Schaeffer M, Daffe M, Duncan K: Functional complementation of the essential gene fabG1 of Mycobacterium tuberculosis by Mycobacterium smegmatis fabG but not Escherichia coli fabG. J. Bacteriol. 189, 3721-3728 (2007).
43. Sassetti CM, Rubin EJ: Genetic requirements for mycobacterial survival during infection. Proc. Natl Acad. Sci. USA 100, 12989-12994 (2003).
44. Vilcheze C, Morbidoni HR, Weisbrod TR et al.: Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis. J. Bacteriol. 182, 4059-4067 (2000).
45. Lee JH, Karakousis PC, Bishai WR: Roles of SigB and SigF in the Mycobacterium tuberculosis sigma factor network. J. Bacteriol. 190, 699-707 (2008).
46. Raman S, Puyang X, Cheng TY, Young DC, Moody DB, Husson RN: Mycobacterium tuberculosis SigM positively regulates Esx secreted protein and nonribosomal peptide synthetase genes and down regulates virulence-associated surface lipid synthesis. J. Bacteriol. 188, 8460-8468 (2006).
47. Wilson M, DeRisi J, Kristensen HH et al.: Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proc. Natl Acad. Sci. USA 96, 12833-12838 (1999).
48. Molle V, Brown AK, Besra GS, Cozzone AJ, Kremer L: The condensing activities of the Mycobacterium tuberculosis type II fatty acid synthase are differentially regulated by phosphorylation. J. Biol. Chem. 281, 30094-30103 (2006).
49. Banerjee A, Dubnau E, Quemard A et al.: inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263, 227-230 (1994).
50. Morlock GP, Metchock B, Sikes D, Crawford JT, Cooksey RC: ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother. 47, 3799-3805 (2003).
51. Glickman MS, Cox JS, Jacobs WR Jr: A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Mol. Cell. 5, 717-727 (2000).
52. Glickman MS, Cahill SM, Jacobs WR Jr: The Mycobacterium tuberculosis cmaA2 gene encodes a mycolic acid trans-cyclopropane synthetase. J Biol. Chem. 276, 2228-2233 (2001).
53. Rao V, Gao F, Chen B, Jacobs WR Jr, Glickman MS: Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis - induced inflammation and virulence. J. Clin. Invest. 116, 1660-1667 (2006).
54. Yuan Y, Lee RE, Besra GS, Belisle JT, Barry CE 3rd: Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 92, 6630-6634 (1995).
55. Dubnau E, Laneelle MA, Soares S et al.: Mycobacterium bovis BCG genes involved in the biosynthesis of cyclopropyl keto- and hydroxy-mycolic acids. Mol. Microbiol. 23, 313-322 (1997).
56. Glickman MS: The mmaA2 gene of Mycobacterium tuberculosis encodes the distal cyclopropane synthase of the α-mycolic acid. J. Biol. Chem. 278, 7844-7849 (2003).
57. Yuan Y, Barry CE 3rd: A common mechanism for the biosynthesis of methoxy and cyclopropyl mycolic acids in Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 93, 12828-12833 (1996).
58. Yuan Y, Crane DC, Musser JM, Sreevatsan S, Barry CE 3rd: MMAS-1, the branch point between cis- and transcyclopropane-containing oxygenated mycolates in Mycobacterium tuberculosis. J. Biol. Chem. 272, 10041-10049 (1997).
59. Boissier F, Bardou F, Guillet V et al.: Further insight into S-adenosylmethionine-dependent methyltransferases: structural characterization of Hma, an enzyme essential for the biosynthesis of oxygenated mycolic acids in Mycobacterium tuberculosis. J. Biol. Chem. 281, 4434-4445 (2006).
60. Dinadayala P, Laval F, Raynaud C et al.: Tracking the putative biosynthetic precursors of oxygenated mycolates of Mycobacterium tuberculosis. Structural analysis of fatty acids of a mutant strain deviod of methoxy- and ketomycolates. J. Biol. Chem. 278, 7310-7319 (2003).
61. Yuan Y, Zhu Y, Crane DD, Barry CE3rd: The effect of oxygenated mycolic acid composition on cell wall function and macrophage growth in Mycobacterium tuberculosis Mol. Microbiol. 29, 1449-1458 (1998).
62. Gande R, Gibson KJ, Brown AK et al.: Acyl-CoA carboxylases ( accD2 and accD3), together with a unique polyketide synthase (Cg-pks), are key to mycolic acid biosynthesis in Corynebacterianeae such as Corynebacterium glutamicum and Mycobacterium tuberculosis. J. Biol. Chem. 279, 44847-44857 (2004).
63. Gokhale RS, Saxena P, Chopra T, Mohanty D: Versatile polyketide enzymatic machinery for the biosynthesis of complex mycobacterial iipids. Nat. Prod. Rep. 24, 267-277 (2007).
64. Portevin D, De Sousa-D'Auria C, Houssin C et al.: A polyketide synthase catalyzes the last condensation step of mycolic acid biosynthesis in mycobacteria. and related organisms. Proc. Natl Acad. Sci. USA 101, 314-319 (2004).
65. Portevin D, De Sousa-D'Auria C, Montrozier H et al.: The acyl-AMP ligase FadD32 and AccD4-containing acyl-CoA carboxylase are required for the synthesis of mycolic acids and essential for mycobacterial growth: identification of the carboxylation product and determination of the acyl-CoA carboxylase components. J. Biol. Chem. 280, 8862-8874 (2005).
66. Lea-Smith DJ, Pyke JS, Tull D, McConville MJ. Coppel RL, Crellin PK: The reductase that catalyzes mycolic motif synthesis is required for efficient attachment of mycolic acids to arabinogalactan. J. Biol. Chem. 282, 11000-11008 (2007).
67. Belisle JT, Vissa VD, Sievert T, Takayama K, Brennan PJ, Besra GS: Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 276, 1420-1422 (1997).
68. Kremer L, Maughan WN, Wilson RA, Dover LG, Besra GS: The M. tuberculosis antigen 85 complex and mycolyltransferase activity. Lett. Appl. Microbiol. 34, 233-237 (2002).
69. Ronning DR, Vissa V, Besra GS, Belisle JT, Sacchettini JC: Mycobacterium tuberculosis antigen 85A and 85C structures confirm binding orientation and conserved substrate specificity. J. Biol. Chem. 279, 36771-36777(2004).
70. Singh A, Gupta R, Vishwakarma RA et al.: Requirement of the mymA operon for appropriate cell wall ultrastructure and persistence of Mycobacterium tuberculosis in the spleens of guinea pigs. J. Bacteriol. 187, 4173-4186 (2005).
71. Singh A, Jain S, Gupta S, Das T, Tyagi AK: mymA operon of Mycobacterium tuberculosis: its regulation and importance in the cell envelope. FEMS Microbiol. Lett. 227, 53-63 (2003).
72. Jackson M, Crick DC, Brennan PJ: Phosphatidylinositol is an essential phospholipid of mycobacteria. J. Biol. Chem. 275, 30092-30099 (2000).
73. Hunter SW, Brennan PJ: Evidence for the presence of a phosphatidylinositol anchor on the lipoarabinomannan and lipomannan of Mycobacterium tuberculosis. J. Biol. Chem. 265, 9272-9279 (1990).
74. Owens RM, Hsu FF, VanderVen BC et al.: M. tuberculosis Rv2252 encodes a diacylglycerol kinase involved in the biosynthesis of phosphatidylinositol mannosides (PIMs). Mol. Microbiol. 60, 1152-1163 (2006).
75. McCarthy TR, Torrelles JB, MacFarlane AS et al.: Overexpression of Mycobacterium tuberculosis manB, a phosphomannomutase that increases phosphatidylinositol mannoside biosynthesis in Mycobacterium smegmatis and mycobacterial association with human macrophages. Mol. Microbiol. 58, 774-790 (2005).
76. Kordulakova J, Gilleron M, Mikusova K et al.: Definition of the first mannosylation step in phosphatidylinositol mannoside synthesis. PimA is essential for growth of mycobacteria. J. Biol. Chem. 277, 31335-31344 (2002).
77. Kordulakova J, Gilleron M, Puzo, G et al.: Identification of the required acyltransferase step in the biosynthesis of the phosphatidylinositol mannosides of mycobacterium species. J. Biol. Chem. 278, 36285-36295 (2003).
78. Tatituri RV, Illarionov PA, Dover LG et al.: Inactivation of Corynebacterium glutamicum NCg10452 and the role of MgtA in the biosynthesis of a novel mannosylated glycolipid involved in lipomannan biosynthests. J. Biol. Chem. 282, 4561-4572 (2007).
79. Kremer L, Gurcha SS, Bifani P et al.: Characterization of a putative α-mannosyltransferase involved in phosphatidylinositol trimannoside biosynthesis in Mycobacterium tuberculosis. Biochem. J. 363, 437-447 (2002).
80. Morita YS, Sena CB, Waller RF et al.: PimE is a polyprenol-phosphate-mannose-dependent mannosyltransferase that transfers the fifth mannose of phosphatidylinositol mannoside in mycobacteria. J. Biol. Chem. 281, 25143-25155 (2006).
81. Kovacevic S, Anderson D, Morita YS et al.: Identification of a novel protein with a role in lipoarabinomannan biosynthesis in mycobacteria. J. Biol. Chem. 281, 9011-9017 (2006).
82. Berg S, Kaur D, Jackson M, Brennan PJ: The glycosyltransferases of Mycobacterium tuberculosis roles in the synthesis of arabinogalactan, lipoarabinomannan, and other glycoconjugates. Glycobiology 17, 35R-56R (2007).
83. Berg S, Starbuck J, Torrelles JB et al.: Roles of conserved proline and glycosyltransferase motifs of EmbC in biosynthesis of lipoarabinomannan. J. Biol. Chem. 280, 5651-5663 (2005).
84. Chatterjee D, Khoo KH: Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects. Glycobiology 8, 113-120 (1998).
85. Chattejee D, Lowell K, Rivoire B, McNeil MR, Brennan PJ: Lipoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains. J. Biol. Chem. 267, 6234-6239 (1992).
86. Kaur D, McNeil MR, Khoo KH et al.: New insights into the biosynthesis of mycobacterial lipomannan arising from deletion of a conserved gene. J. Biol. Chem. 282, 27133-27140 (2007).
87. Mishra AK, Alderwick LJ, Rittmann D et al.: Identification of an a(l→6) mannopyranosyltransferase (MptA), involved in Corynebacterium glutamicum lipomanann biosynthesis, and identification of its orthologue, in Mycobacterium tuberculosis. Mol. Microbiol. 65, 1503-1517 (2007).
88. Kaur D, Berg S, Dinadayala P et al.: Biosynthesis of mycobacterial lipoarabinomannan: role of a branching mannosyltransferase. Proc. Natl Acad. Sci. USA 103, 13664-13669 (2006).
89. Shi L, Berg S, Lee A et al.: The carboxy terminus of EmbC from Mycobacterium smegmatis mediates chain length extension of the arabinan in lipoarabinomannan. J. Biol. Chem. 281, 19512-19526 (2006).
90. Fratti RA, Chua J, Vergne I, Deretic V: Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc. Natl Acad. Sci. USA 100, 5437-5442 (2003).
91. Geijtenbeek TB, Van Vliet SJ, Koppel EA et al.: Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 197, 7-17 (2003).
92. Knutson KL, Hmama Z, Herrera-Velit P, Rochford R, Reiner NE: Lipoarabinomannan of Mycobacterium tuberculosis promotes protein tyrosine dephosphorylation and inhibition of mitogen-activated protein kinase in human mononuclear phagocytes. Role of the Src homology 2 containing tyrosine phosphatase 1. J. Biol. Chem. 273, 645-652 (1998).
93. Maeda N, Nigou J, Herrmann JL et al.: The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan. J. Biol. Chem. 278, 5513-5516 (2003).
94. Nigou J, Zelle-Rieser C, Gilleron M, Thurnher M, Puzo G: Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J. Immunol. 166, 7477-7485 (2001).
95. Tailleux L, Schwartz O, Herrmann JL et al.: DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J. Exp. Med. 197, 121-127 (2003).
96. Appelmelk BJ, Den Dunnen J, Driessen NN et al.: The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacterium-host interaction. Cell. Microbiol. 10(4), 930-944 (2007).
97. Dinadayala P, Kaur D, Berg S et al.: Genetic basis for the synthesis of the immunomodulatory mannose caps of lipoarabinomannan in Mycobacterium tuberculosis. J. Biol. Chem. 281, 20027-20035 (2006).
98. Matsuba T, Suzuki Y, Tanaka Y: Association of the Rv0679c protein with lipids and carbohydrates in Mycobacterium tuberculosis/Mycobacterium bovis BCG. Arch. Microbiol. 187, 297-311 (2007).
99. Camacho LR, Constant P, Raynaud C et al.: Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier. J. Biol. Chem. 276, 19845-19854 (2001).
100. Cox JS, Chen B, McNeil M, Jacobs WR Jr: Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 402, 79-83 (1999).
101. Azad AK, Sirakova TD, Fernandes ND, Kolattukudy PE: Gene knockout reveals a novel gene cluster for the synthesis of a class of cell wall lipids unique to pathogenic mycobacteria. J. Biol. Chem. 272, 16741-16745 (1997).
102. Onwueme KC, Ferreras JA, Buglino J, Lima CD, Quadri LE: Mycobacterial polyketide-associated proteins are acyltransferases: proof of principle with Mycobacterium tuberculosis PapA5. Proc. Natl Acad. Sci. USA 101, 4608-4613 (2004).
103. Sulzenbacher G, Canaan S, Bordat Y et al.: LppX is a lipoprotein required for the translocation of phthiocerol dimycocerosates to the surface of Mycobacterium tuberculosis. EMBO J. 25, 1436-1444 (2006).
104. Perez J, Garcia R, Bach H et al.: Mycobacterium tuberculosis transporter MmpL7 is a potential substrate for kinase PknD. Biochem. Biophys. Res. Commun. 348, 6-12 (2006).
105. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K: Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43, 717-731 (2002).
106. Muttucumaru DG, Roberts G, Hinds J, Stabler RA, Parish T: Gene expression profile of Mycobacterium tuberculosis in a non-replicating state. Tuberculosis (Edinb.) 84, 239-246 (2004).
107. Sun R, Converse PJ, Ko C, Tyagi S, Morrison NE, Bishai WR: Mycabacterium tuberculosis ECF sigma factor sigCis required for lethality in mice and for the conditional expression of a defined gene set. Mol. Microbiol. 52, 25-38 (2004).
108. Dainese E, Rodrigue S, Delogu G et al.: Postranslational regulation of Myrobacterium tuberculosis extracytoplasmic-function sigma factor sigma L and roles in virulence and in global regulation of gene expression. Infect. Immun. 74, 2457-2461 (2006).
109. Sirakova TD, Dubey VS, Cynamon MH, Kolattukudy PE: Attenuation of Mycobacterium tuberculosis by disruption of a mas-like gene or a chalcone synthase-like gene, which causes deficiency in dimycocerosyl phthiocerol synthesis. J. Bacteriol. 185, 2999-3008 (2003).
110. Sirakova TD, Fitzmaurice AM, Kolattukudy P: Regulation of expression of mas and fadD28, two genes involved in production of dimycocerosyl phthiocerol, a virulence factor of Mycobacterium tuberculosis. J. Bacteriol. 184, 6796-6802 (2002).
111. Reed MB, Domenech P, Manca C et al.: A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431, 84-87 (2004).
112. Tsenova L, Ellison E, Harbacheuski R et al.: Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. J. Infect. Dis. 192, 98-106 (2005).
113. Perez E, Constant P, Lemassu A, Laval F, Daffe M, Guilhot C: Characterization of three glycosyltransferases involved in the biosynthesis of the phenolic glycolipid antigens from the Mycobacterium tuberculosis complex. J. Biol. Chem. 279, 42574-42583 (2004).
114. Constant P, Perez E, Malaga W et al.: Role of the pks15/1 gehe in the biosynthesis of phenolglycolipids in the Mycobacterium tuberculosis complex. Evidence that all strains synthesize glycosylated p-hydroxybenzoic methyl esters and that strains devoid of phenolglycolipids harbor a frameshift mutation in the pks15/1 gene. J. Biol. Chem. 277, 38148-38158 (2002).
115. + lymphocytes. Microbiology 153, 3360-3369 (2007).
116. Murphy HN, Stewart GR, Mischenko, VV et al.: The OtsAB pathway is essential for trehalose biosynthesis in Mycobacterium tuberculosis. J. Biol. Chem. 280, 14524-14529 (2005).
117. Rousseau C, Turner OC, Rush E et al.: Sulfolipid deficiency does not affect the virulence of Mycobacterium tuberculosis H37Rv in mice and guinea pigs. Infect. Immun. 71, 4684-4690 (2003).
118. Goren MB, Brokl O, Das BC: Sulfatides of Mycobactarium tuberculosis: the structure of the principal suffaticle (SL-I). Biochemistry 15, 2728-2735 (1976).
119. Mougous JD, Petzold CJ, Senaratne RH et al.: Identification, function and structure of the mycobacterial sulfotransferase that initiates sulfolipid-1 biosynthesis. Nat. Struct. Mol. Biol. 11, 721-729 (2004).
120. Rivera-Marrero CA, Ritzenthaler JD, Newburn SA, Roman J, Cummings RD: Molecular cloning and expression of a novel glycolipid sulfotransferase in Mycobacterium tuberculosis. Microbiology 148, 783-792 (2002).
121. Sirakova TD, Thirumala AK, Dubey VS, Sprecher H, Kolattukudy PE: The Mycobacterium tubercosis pks2 gene encodes the synthase for the hepta- and octamethyl-branched fatty acids required for sulfolipid synthesis. J. Biol. Chem. 276, 16833-16839 (2001).
122. Gonzalo Asensio J, Maia C, Ferrer NL et al.: The. virulence-associated two-component PhoP-PhoR system controls the biosynthesis of polyketide-derived lipids in Mycobacterium tuberculosis. J. Biol. Chem. 281, 1313-1316 (2006).
123. Walters SB, Dubnau E, Kolesnikova I, Laval F, Daffe M, Smith I: The Mycobacterium tuberculosis PhoPR two-component system regulates genes essential for virulence and complex lipid biosynthesis. Mol. Microbiol. 60, 312-330 (2006).
124. Gago G, Kurth D, Diacovich L, Tsai SC, Gramajo H: Biochemical and structural characterization of an essential acyl coenzyme A carboxylase from Mycobacterium tuberculosis. J. Bacteriol. 188, 477-486 (2006).
125. Jain M, Petzold CJ, Schelle MW et al.: Lipidomics reveals control of Mycobacterium tuberculosis virulence lipids via metabolic coupling. Proc. Natl Acad. Sci. USA 104, 5133-5138 (2007).
126. Daffe M, Etienne G: The capsule of Mycobacterium tuberculosis and its implications for pathogenicity. Tuber. Lung. Dis. 79, 153-169 (1999).